Chase AIPricingFAQs
Display currency
Loading news…

Pieris

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Hallbergmoos, Bayern, Germany Founded 2001 101-250 employees For Profit

Pieris is a clinical-stage biotechnology company that develops drugs to fight cancer, severe asthma, anemia, and so on.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
0
Ticker
PI6
FRA - Frankfurt Stock Exchange
Patents
18
4 trademarks

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Public
Ticker
PI6
Exchange
FRA - Frankfurt Stock Exchange
IPO date
Jul 17, 2015

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
10
Patents granted
18
Trademarks
4
Top patent class
Organic Chemistry

Company Info

Founded
2001
Employees
101-250
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
News articles
3
HQ
Hallbergmoos, Bayern, Germany
Region
European Union (EU), Europe, Middle East, and Africa (EMEA)
Exit date
Jul 17, 2015

Signals & Scores

Heat score
Medium
Growth score
Low
Trend (7d)
-0.2
Trend (30d)
0.1
Trend (90d)
1.4

Key People at Pieris

COO
CEO/CFO and Co-founder

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Pieris

Loading news…

FAQs about Pieris

People who checked this page also checked these

Browse the full Acquirezy directory.
Pieris - Company Profile, Full Acquisitions List, Funding and Investments